This would be most likely if retatrutide severely suppresses your appetite or if gastrointestinal issues such as nausea interfere with eating
Licensed pharmacological options for weight management in the UK include: Semaglutide (Wegovy, 2.4 mg weekly) a GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI 30 kg/m, or 27 kg/m with at least one weight-related comorbidity
The ever-expanding myokinome: discovery challenges and therapeutic implications
c bit, n cng gip nh bay nm, tn nhang, vt thm i mi
Malaguarnera M, Cammalleri L, Gargante MP, et al
Preclinical studies indicate that BSA@LIR-PMF effectively targets inflamed vascular sites and demonstrates substantial therapeutic efficacy, supporting its potential as a clinically translatable nanomedicine platform for cardiovascular intervention in diabetic patients [161] ( Fig